Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huanli Sun

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Biomacromolecules|October 30, 2019
Cancer Nanomedicines Based on Synthetic PolypeptidesHuanli Sun, Xiaolei Gu, Qiang Zhang, et al.
Biomacromolecules|April 8, 2011
α-Amino acid containing degradable polymers as functional biomaterials: rational design, synthetic pathway, and biomedical applicationsHuanli Sun, Fenghua Meng, Aylvin A Dias, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 18, 2016
α<sub>v</sub>β<sub>3</sub> Integrin-targeted reduction-sensitive micellar mertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivoPing Zhong, Hao Meng, Jie Qiu, et al.
Biomacromolecules|March 9, 2010
Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicinHuanli Sun, Bingnan Guo, Xiaoqing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2018
Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivoMin Qiu, Huanli Sun, Fenghua Meng, et al.
Biomaterials Science|April 19, 2018
Polytyrosine nanoparticles enable ultra-high loading of doxorubicin and rapid enzyme-responsive drug releaseXiaolei Gu, Min Qiu, Huanli Sun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 23, 2019
cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivoXiaolei Gu, Yaohua Wei, Qianyi Fan, et al.
Biomacromolecules|September 19, 2019
CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors <i>in Vivo</i>Huimin Fang, Xiaofei Zhao, Xiaolei Gu, et al.
Biomacromolecules|August 25, 2017
Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for LeukemiaJie Qiu, Ru Cheng, Jian Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2022
Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapyJingyi Liu, Lei Zhang, Dongxu Zhao, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Biomacromolecules|October 30, 2019
Cancer Nanomedicines Based on Synthetic PolypeptidesHuanli Sun, Xiaolei Gu, Qiang Zhang, et al.
Biomacromolecules|April 8, 2011
α-Amino acid containing degradable polymers as functional biomaterials: rational design, synthetic pathway, and biomedical applicationsHuanli Sun, Fenghua Meng, Aylvin A Dias, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 18, 2016
α<sub>v</sub>β<sub>3</sub> Integrin-targeted reduction-sensitive micellar mertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivoPing Zhong, Hao Meng, Jie Qiu, et al.
Biomacromolecules|March 9, 2010
Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicinHuanli Sun, Bingnan Guo, Xiaoqing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2018
Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivoMin Qiu, Huanli Sun, Fenghua Meng, et al.
Biomaterials Science|April 19, 2018
Polytyrosine nanoparticles enable ultra-high loading of doxorubicin and rapid enzyme-responsive drug releaseXiaolei Gu, Min Qiu, Huanli Sun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 23, 2019
cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivoXiaolei Gu, Yaohua Wei, Qianyi Fan, et al.
Biomacromolecules|September 19, 2019
CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors <i>in Vivo</i>Huimin Fang, Xiaofei Zhao, Xiaolei Gu, et al.
Biomacromolecules|August 25, 2017
Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for LeukemiaJie Qiu, Ru Cheng, Jian Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2022
Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapyJingyi Liu, Lei Zhang, Dongxu Zhao, et al.
Pageof 7